Book References:

Chapter 2

Soni KB, Kuttan R. Effect of oral curcumin administration on serum peroxides and cholesterol levels in human volunteers. Indian J Physiol Pharmacol. 1992 Oct;36(4):273–275.

Ramaswami G, Chair H et al. Curcumin blocks homocysteine-induced endothelial dysfunction in porcine coronary arteries. J Vasc Surg. 2004 Dec;40(6): 1216–22.

Shar BH, Nawaz Z. Inhibitory effect of curcumin, a food spice from turmeric, on platelet-activating factor- and arachidonic acid-mediated platelet aggregation through inhibition of thromboxane formation and Ca2+ signaling. Biochem Pharmacol. 1999 Oct 1;58(7):11 67–72.

Li HL, Liu C et al. Curcumin prevents and reverses murine cardiac hypertrophy. J Clin Invest. 2008 Feb 21.

Zhao J, Zhao Y et al. Neuroprotective effect of curcumin on transient focal cerebral ischemia in rats. Brain Res. 2008 Sep 10;1229:224–32. Epub 2008 Jul 8.

Chapter 3

Aggarwal BB, Kumar A et al. Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res. 2003 Jan–Feb;23(1A):363–398.

Link A, Balaquer F. Cancer chemoprevention by dietary polyphenols: promising role for epigenetics. Biochem Pharmacol. 2010 Dec 15;80(12):1771–92. Epub 2010 Jun 26.

Anand P, Sundaram C. Curcumin and cancer: an “old-age” disease with an “ageold” solution. Cancer Lett. 2008 Aug 18;267(1):133–164. Epub 2008 May 6.

Ireson CR, Jones DJ et al. Metabolism of the cancer chemopreventive agent curcumin in human and rat intestine. Cancer Epidemiol Biomarkers Prev. 2002; 11(1):105–111.

Cheng AL, Hsu CH et4 al. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res. 2001;21(4B):2895–2900.

Nanji AA, Jokelainen K et al. Curcumin prevents alcohol-induced liver disease in rats by inhibiting the expression of NF-kappa B-dependent genes. Am J Physiol Gastrointest Liver Physiol. 2003 Feb;284(2):G321–7. Epub 2002 Aug 28.

Chapter 4

Chandran B, Goel A. A randomized study to assess the efficacy and safety of curcumin in patients with active rheumatoid arthritis. Phytother Res. March 9, 2012 doi: 10.1002/ptrr.4639.

Antony B, Kizhakedath et al. Clinical evaluation of a herbal product (Rhulief™) in the management of knee osteoarthritis. Abstract 316. Osteoarthritis Cartilage. 2011; 19(S1): S145-S146.

Rao TS, Basu N et al. Anti-inflammatory activity of curcumin analogues. Indian J Med Res. 1982 Apr;75:574–578.

Funk JL, Ovarzo JN et al. Turmeric extracts containing curcuminoids prevent experimental rheumatoid arthritis. J Nat Prod. 2006 Mar;69(3):351–355.

Chapter 4 -continued

Aggarwal BB, Sung B. Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets. Trends Pharmacol Sci. 2009; 30:85–94.

Liacini A, Sylvester J et al. Induction of matrix metalloproteinase-13 gene expression by TNF-alpha is mediated by MAP kinases, AP-1, and NF-kappaB transcription factors in articular chondrocytes. J. Exp Cell Res. 2003 Aug 1;288(1): 208–217.

Chapter 5

Fujiwara H, Hosokawa M et al. Curcumin inhibits glucose production in iso lated mice hepatcytes. Diabetes Res Clin Pract. 2008 May;80(2):185–91. Epub 2008 Jan 24.

Weisberg SP, Leibel R et al. Dietary Curcumin Significantly Improves Obesity-Associated Inflammation and Diabetes in Mouse Models of Diabesity. Endocrinology. 2008 Jul;149(7):3549–58. Epub 2008 Apr 10.

Kulkarni SK, Chopra K. Curcumin the active principle of turmeric (Curcuma longa), ameliorates diabetic nephropathy in rats. Clin Exp Pharmacol Physiol.
2006 Oct;33(10):940–945.

Chapter 6

DepressionSanmukhani J, Anovadiya A et al. Evaluation of antidepressant like activity of curcumin and its combination with fluoxetine and imipramine: an acute and chronic study. Acta Pol Pharm. 2011 Sep-Oct;68(5):769–75.

Garcia-Alloza M, Borrelli LA et al. Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model, J. Neurochem. 102 (2007) 1095–1104.

Baker CB. Quantitative Analysis of Sponsorship Bias in Economic Studies of Antidepressants. The British Journal of Psychiatry. 2003, 183:498–506.

Kulkarni S, Dhir A et al. Potentials of curcumin as an antidepressant. Scientific-WorldJournal. 2009 Nov 1;9:1233–41.

Kulkarni S, Bhutani MK et al. Antidepressant activity of curcumin: involvement of serotonin and dopamine system. Psychopharmacology (Berl). 2008 Dec;201(3):435–42. Epub 2008 Sep 3.

DementiaBaum L et al. Six-month randomized placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer’s Disease. Journal of Clinical Psychopharmacology. Vol 28, Number 1, Feb 2008 pg 110–114.

Xu Y, Ku B et al. Curcumin reverses impaired hippocampal neurogenesis and increases serotonin receptor 1A mRNA and brain-derived neurotrophic factor expression in chronically stressed rats. Brain Res.
2007 Aug 8;1162:9–18. Epub 2007 Jun 21.

Lim GP, Chu T et al. The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse.
J Neurosci. 2001 Nov 1;21(21):8370–77.